News
New EDCTP programme celebrated in Cape Town, South Africa on 2 December 2014
The meeting will offer a full day of reflection and discussion on overarching topics regarding the new programme. Opening addresses will be delivered by: Naledi…
World Aids Day 2014: second EDCTP programme starts December 2, 2014
EDCTP2 will be inaugurated tomorrow at a high-level meeting in Cape Town, South Africa. It will bring together public and private funders, the pharmaceutical industry…
Forum Proceedings and Forum video published
The Proceedings of the Seventh EDCTP Forum, held in Berlin, Germany from 30 June to 2 July 2014, are published on the EDCTP website today.…
Scholarships for MSc programma in vaccinology in Siena, Italy
The University of Siena Medical School, Novartis Vaccines and Diagnostics, Novartis Vaccines Institute for Global Health (NVGH), and the ADITEC (Advanced Immunization Technologies) programme invite…
EDCTP and TDR offer first joint Clinical R&D Fellowships
A total of 25 fellowships is available for this call; 20 product development organisations have offered to host fellows. The host organisations will train individuals…
New drug combination could improve adherence to tuberculosis treatment
A novel combination of the drugs rifapentine and moxifloxacin can reduce the number of tablets to be taken by patients from 360 to 140 (administered…
Mefloquine not recommended as alternative drug for malaria prevention treatment in pregnancy
The results of two large randomised controlled trials conducted in Africa that tested mefloquine, a drug for malaria prevention in HIV-negative and HIV-positive pregnant women,…
Proceedings of the EDCTP stakeholder meeting on capacity development published
The European & Developing Countries Clinical Trials Partnership (EDCTP) has published its report of the Stakeholder meeting on capacity development today. The meeting was held…
Current state of health research on poverty-related diseases in sub-Saharan Africa
Today, the European & Developing Countries Clinical Trials Partnership (EDCTP), RAND Europe and Baird’s CMC have published a report on the current state of health…
REMoxTB trial results confirm moxifloxacin safety but not shortened tuberculosis treatment
Prof. Charles Mgone, EDCTP Executive Director: “A shorter treatment regimen would have great significance for individual patients and TB care programmes alike. Unfortunately, this goal…
Launch of the second EDCTP programme against poverty-related diseases in Africa
The high-level event expects to welcome approximately 200 delegates, including African and European government representatives, major research funders, scientists, industry representatives and other experts in…
TAM-TB: New sputum-independent diagnostic tool for tuberculosis in children
Today, The Lancet Infectious Diseases published the results of a sputum-independent assay developed in Tanzania that is able to diagnose active tuberculosis in children. The…
Results of trial to assess second-line therapy in HIV patients in Africa published
The combination of a boosted protease inhibitor (lopinavir) with two nucleoside reverse-transcriptase inhibitors (NRTIs) is a feasible second-line therapy for HIV patients in Africa. These…
EDCTP Annual Report 2013 available online
The interactive EDCTP Annual Report 2013 “The First Decade” is now available on the website. It gives access to the complete Annual Report 2013 in…
International clinical trials day: EDCTP extends its gratitude to all clinical trial volunteers
Clinical trials depend on the participation of volunteers, both the healthy and those suffering from disease. Their dedication based on free and well informed consent…